Malignant potential of epithelioid angiomyolipomas of the liver: A case report and comprehensive review of the literature

Garoufalia,Zoe; Machairas,Nikolaos; Kostakis,Ioannis D.; Liakea,Aliki; Tsaparas,Petros; Liapis,George; Sotiropoulos,Georgios  C.

doi:10.3892/mco.2018.1659

Malignant potential of epithelioid angiomyolipomas of the liver: A case report and comprehensive review of the literature

Authors:
- Zoe Garoufalia
- Nikolaos Machairas
- Ioannis D. Kostakis
- Aliki Liakea
- Petros Tsaparas
- George Liapis
- Georgios C. Sotiropoulos
View Affiliations

Affiliations: Second Department of Propaedeutic Surgery, Laiko General Hospital, 11527 Athens, Greece, First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
Published online on: June 15, 2018 https://doi.org/10.3892/mco.2018.1659
Pages: 226-230

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatic epithelioid angiomyolipoma (HEAML) is a rare mesenchymal tumor that has been reported to have malignant potential. We herein describe a rare case of atypical HEAML. A 43‑year‑old Caucasian male patient visited his general practitioner due to a productive cough persisting for >2 months. During evaluation with several imaging tests, a chest computed tomography (CT) incidentally revealed a well‑demarcated lesion in the caudate lobe of the liver, sized 7 cm. An abdominal magnetic resonance imaging examination confirmed the findings of the CT. The possibility of hepatocellular carcinoma at that time could not be excluded. Due to inconclusive cross‑sectional imaging, the patient underwent left hepatectomy with additional resection of segment I. The patient's postoperative course was uneventful. A diagnosis of ‘atypical’ HEAML was established in the present case. The majority of HEAMLs are considered to be benign, although there are several reported cases exhibiting malignant behavior, such as tumor growth, presence of atypical cells, recurrence after surgical resection, metastasis and invasive growth into the liver parenchyma and alongside the vessels. From 2000 onwards, 19 cases of malignant hepatic AML have been reported. Malignant transformation is considered to occur mostly in the epithelioid subtype. To that end, when epithelioid or atypical characteristics are identified on preoperative biopsy, resection is indicated due to the high probability of malignancy.

View Figures

View References

1	Fletcher CD, Unni KK and Mertens F: World Health Organization Classification of Tumors of Pathology and Genetics: Tumors of Soft Tissue and Bone. 4. IARC Press; Lyon, France: 2002
2	Folpe AL and Kwiatkowski DJ: Perivascular epithelioid cell neoplasms: Pathology and pathogenesis. Hum Pathol. 41:1–15. 2010. View Article : Google Scholar : PubMed/NCBI
3	Klompenhouwer AJ, Verver D, Janki S, Bramer WM, Doukas M, Dwarkasing RS, de Man RA and IJzermans JNM: Management of hepatic angiomyolipoma: A systematic review. Liver Int. 37:1272–1280. 2017. View Article : Google Scholar : PubMed/NCBI
4	Yamasaki S, Tanaka S, Fujii H, Matsumoto T, Okuda C, Watanabe G and Suda K: Monotypic epithelioid angiomyolipoma of the liver. Histopathol. 36:451–456. 2000. View Article : Google Scholar
5	Liu J, Zhang CW, Hong DF, Tao R, Chen Y, Shang MJ and Zhang YH: Primary hepatic epithelioid angiomyolipoma: A malignant potential tumor which should be recognized. World J Gastroenterol. 22:4908–4917. 2016. View Article : Google Scholar : PubMed/NCBI
6	Dalle I, Sciot R, de Vos R, Aerts R, van Damme B, Desmet V and Roskams T: Malignant angiomyolipoma of the liver: A hitherto unreported variant. Histopathol. 36:443–450. 2000. View Article : Google Scholar
7	Hornick JL and Fletcher CD: PEComa: What do we know so far? Histopathol. 48:75–82. 2006. View Article : Google Scholar
8	Mai KT, Perkins DG and Collins JP: Epithelioid cell variant of renal angiomyolipoma. Histopathol. 28:277–280. 1996. View Article : Google Scholar
9	Cai PQ, Wu YP, Xie CM, Zhang WD, Han R and Wu PH: Hepatic angiomyolipoma: CT and MR imaging findings with clinical-pathologic comparison. Abdom Imaging. 38:482–489. 2013. View Article : Google Scholar : PubMed/NCBI
10	Nonomura A, Enomoto Y, Takeda M, Takano M, Morita K and Kasai T: Angiomyolipoma of the liver: A reappraisal of morphological features and delineation of new characteristic histological features from the clinicopathological findings of 55 tumours in 47 patients. Histopathol. 61:863–880. 2012. View Article : Google Scholar
11	Yang L, Xu Z, Dong R, Fan J, Du Y, Zhang Y, Wang X, Cheng X and Guo J: Is surgery necessary for patients with hepatic angiomyolipoma? Retrospective analysis from eight Chinese cases. J Gastroenterol Hepatol. 28:1648–1653. 2013.PubMed/NCBI
12	Yang X, Li A and Wu M: Hepatic angiomyolipoma: Clinical, imaging and pathological features in 178 cases. Med Oncol. 30:4162013. View Article : Google Scholar : PubMed/NCBI
13	Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, Nakanuma Y, Snover DC, Bioulac-Sage P and Dhillon AP: Hepatic angiomyolipoma: A clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 23:34–48. 1999. View Article : Google Scholar : PubMed/NCBI
14	Yang XY: Hepatic angiomyolipoma: Radiologic-pathologic correlation and clinical features in 178 cases. HPB. 15:1042013.PubMed/NCBI
15	Wang SY, Kuai XP, Meng XX, Jia NY and Dong H: Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma. Abdom Imaging. 39:323–333. 2014. View Article : Google Scholar : PubMed/NCBI
16	Ji JS, Lu CY, Wang ZF, Xu M and Song JJ: Epithelioid angiomyolipoma of the liver: CT and MRI features. Abdom Imaging. 38:309–314. 2013. View Article : Google Scholar : PubMed/NCBI
17	Krebs S, Esposito I, Lersch C, Gaa J, Schmid RM and Ebert O: Preoperative radiological characterization of hepatic angiomyolipoma using magnetic resonance imaging and contrast-enhanced ultrasonography: A case report. J Med Case Rep. 26:4812011. View Article : Google Scholar
18	Chang Z, Zhang JM, Ying JQ and Ge YP: Characteristics and treatment strategy of hepatic angiomyolipoma: A series of 94 patients collected from four institutions. J Gastrointestin Liver Dis. 20:65–69. 2011.PubMed/NCBI
19	Choi WT, Ramachandran R and Kakar S: Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Hum Pathol. 63:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
20	Chen ZE and Lin F: Application of immunohistochemistry in gastrointestinal and liver neoplasms: New markers and evolving practice. Arch Pathol Lab Med. 139:14–23. 2015. View Article : Google Scholar : PubMed/NCBI
21	Geller SA, Dhall D and Alsabeh R: Application of immunohistochemistry to liver and gastrointestinal neoplasms: Liver, stomach, colon, and pancreas. Arch Pathol Lab Med. 132:490–499. 2008.PubMed/NCBI
22	Mete O and van der Kwast TH: Epithelioid angiomyolipoma: A morphologically distinct variant that mimics a variety of intra-abdominal neoplasms. Arch Pathol Lab Med. 135:665–670. 2011.PubMed/NCBI
23	Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL and Weiss SW: Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: A clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 29:1558–1575. 2005. View Article : Google Scholar : PubMed/NCBI
24	Kamimura K, Nomoto M and Aoyagi Y: Hepatic angiomyolipoma: Diagnostic findings and management. Int J Hepatol. 2012:4107812012. View Article : Google Scholar : PubMed/NCBI
25	Nese N, Martignoni G, Fletcher CD, Gupta R, Pan CC, Kim H, Ro JY, Hwang IS, Sato K, Bonetti F, et al: Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: Detailed assessment of morphology and risk stratification. Am J Surg Pathol. 35:161–176. 2011. View Article : Google Scholar : PubMed/NCBI
26	Mizuguchi T, Katsuramaki T, Nobuoka T, Nishikage A, Oshima H, Kawasaki H, Kimura S, Satoh M and Hirata K: Growth of hepatic angiomyolipoma indicating malignant potential. J Gastroenterol Hepatol. 19:1328–1330. 2004. View Article : Google Scholar : PubMed/NCBI
27	Flemming P, Lehmann U, Becker T, Klempnauer J and Kreipe H: Common and epithelioid variants of hepatic angiomyolipoma exhibit clonal growth and share a distinctive immunophenotype. Hepatology. 32:213–217. 2000. View Article : Google Scholar : PubMed/NCBI
28	Rouquie D, Eggenspieler P, Algayres JP, Béchade D, Camparo P and Baranger B: Malignant-like angiomyolipoma of the liver: Report of one case and review of the literature. Ann Chir. 131:pp. 338–341. 2006, (In French). View Article : Google Scholar : PubMed/NCBI
29	Kamimura K, Oosaki A, Sugahara S, Mori S, Moroda T, Satoh O, Morita T, Kimura K, Kamura T, Nomoto M and Aoyagi Y: Malignant potential of hepatic angiomyolipoma: Case report and literature review. Clin J Gastroenterol. 3:104–110. 2010. View Article : Google Scholar : PubMed/NCBI
30	Fukuda Y, Omiya H, Takami K, Mori K, Kodama Y, Mano M, Nomura Y, Akiba J, Yano H, Nakashima O, et al: Malignant hepatic epithelioid angiomyolipoma with recurrence in the lung 7 years after hepatectomy: A case report and literature review. Surg Case Rep. 2:312016. View Article : Google Scholar : PubMed/NCBI
31	Deng YF, Lin Q, Zhang SH, Ling YM, He JK and Chen XF: Malignant angiomyolipoma in the liver: A case report with pathological and molecular analysis. Pathol Res Pract. 204:911–918. 2008. View Article : Google Scholar : PubMed/NCBI
32	Parfitt JR, Bella AJ, Izawa JI and Wehrli BM: Malignant neoplasm of perivascular epithelioid cells of the liver. Arch Pathol Lab Med. 130:1219–1222. 2006.PubMed/NCBI
33	Hu WG, Lai EC, Liu H, Li AJ, Zhou WP, Fu SY, Pan ZY, Huang G, Lei Y, Lau WY and Wu MC: Diagnostic difficulties and treatment strategy of hepatic angiomyolipoma. Asian J Surg. 34:158–162. 2011. View Article : Google Scholar : PubMed/NCBI
34	Kobayashi Y, Kamimura K, Nomoto M, Sugitani S and Aoyagi Y: Immunohistochemical character of hepatic angiomyolipoma: For its management. Case Rep Med. 2013:2981432013. View Article : Google Scholar : PubMed/NCBI
35	Yang CY, Ho MC, Jeng YM, Hu RH, Wu YM and Lee PH: Management of hepatic angiomyolipoma. J Gastrointest Surg. 11:452–457. 2007. View Article : Google Scholar : PubMed/NCBI
36	Nguyen TT, Gorman B, Shields D and Goodman Z: Malignant hepatic angiomyolipoma: Report of a case and review of literature. Am J Surg Pathol. 32:pp. 793–798. 2008, View Article : Google Scholar : PubMed/NCBI
37	Croquet V, Pilette C, Aubé C, Bouju B, Oberti F, Cervi C, Arnaud JP, Rousselet MC, Boyer J and Calès P: Late recurrence of a hepatic angiomyolipoma. Eur J Gastroenterol Hepatol. 12:579–582. 2000. View Article : Google Scholar : PubMed/NCBI
38	Ding GH, Liu Y, Wu MC, Yang GS, Yang JM and Cong WM: Diagnosis and treatment of hepatic angiomyolipoma. J Surg Oncol. 103:807–812. 2011. View Article : Google Scholar : PubMed/NCBI
39	Wang WT, Li ZQ, Zhang GH, Guo Y and Teng MJ: Liver transplantation for recurrent posthepatectomy malignant hepatic angiomyolipoma: A case report. World J Gastroenterol. 21:3755–3758. 2015. View Article : Google Scholar : PubMed/NCBI
40	Xu PJ, Shan Y, Yan FH, Ji Y, Ding Y and Zhou ML: Epithelioid angiomyolipoma of the liver: Cross-sectional imaging findings of 10 immunohistochemically-verified cases. World J Gastroenterol. 15:4576–4581. 2009. View Article : Google Scholar : PubMed/NCBI